Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If approved by FDA.
10,000 Covid antibody blood donations have been performed over past 6 weeks. DB studies won’t be known for 3 months.
At our local hospital it’s the “go to” treatment even though it doesn’t have significant results. There is some anecdotal evidence it helps a few.
MOA of leronlimab seems better.
Based on MOA, Leronlimab should easily help those kids. It’s a shame that it’ll be 6 months or more before they’re allowed to indicate it for Kawasaki.
Can you imagine if leronlimab is approved for adults and not kids? The public backlash will be extreme.
Ok, thanks. You know how it goes Stocks tend to move before the data is released, especially in the Pinks.
Yep, they won’t mention it until after the DB study success.
Congress already is a little pissy about AFs screwup pumping Gilead so they won’t namedrop CytoDyn and cause a PPs spike.
Closest they’ve come is “monoclonal antibodies” but Fauci quickly changes the subject to Remdesivir (for obvious reasons).
Does NP get any inside info on the blinded trials mid way?
Might, but it doesn’t sound like there is one. I’ll just keep checking in once a quarter unless we see some volume.
Yeah.... need more of that. We can’t keep taking shots at each other all day. Give us some fresh material G-Money.
Oh he’s not dumb. But he also knows it takes money to make money. He’s betting on himself right now.
Yes, very concerning. In this world though shady people stumble upon gold mines all the time. So long as the world (and us) benefits from their need for greed then I’m fine with it. If leronlimab truly works then oh my.
Those in the know aren’t surprised.
The way I understand it that’s not the MOA of leronlimab. Leronlimab masks the Rantes from the immune system so the cytokine storm is reduced (the CCL5 block). It restores homeostasis of the immune system which allows the T8 cells to reduce viral load and consequently Rantes expression.
Yes, they learn more everyday so that’s why they shifted from a IL6
To Rantes. They know leronlimab works but they are trying to clearly define the leronlimab moa for the medical Community.
Lol... agreed
Yeah, I didn’t agree with NP’s assessment that the EU would wait on the FDA.
Not following... BP was just one of many who confirmed elevated Rantes. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3576836
It’ll be more commonplace after some peer reviews. If BPs paper is not accepted then uh oh, but he’s well respected and his data is corroborated by other doctors so he’s likely in the clear.
That’s why $100 PPS isn’t far off as most think.
The EU would not proceed without FDA approval per NP. However, Mexico doesn’t give a damn. The non-westernized countries could take the lead and NP would have a tough choice. He’s said numerous times he wants to lead with fda approval first.
Still under the chill? Must’ve given up. Change of ownership? New ticker? How about GEMS?
Sounds like other doctors have similar findings to BP with regards to Rantes. NP will be busy for a long time.
What’s Naders next catalyst? Uplist? I think he’s awhile out on PRs and FDA action.
No doubt he’ll keep pumping and promoting to get leronlimab exposure. I don’t blame him there. A Naz uplist would open up more equity markets for sure.
Lol... why can’t he do that for VYST then?
Horrible management at VYST. They have no idea how to run a pubco.
That’s huge news. Why wouldn’t NP PR that?
Yeah, everyone makes that mistake. Reporters have deadlines...
Don’t listen to short positions
https://clinicaltrials.gov/ct2/results?cond=&term=Leronlimab+&cntry=&state=&city=&dist=
Greg forgot to do his job again
Who knows for sure? We have one picture and no evidence of sales. Sounds like they made 50 and want to test before selling them. By testing I’m not sure if that means they want recertification by FDA due to the improvements they made to address customer complaints? That could take a long time... FDA is kinda busy.
Yes, VYST has the inside track... can they take it home? Exciting race , we’re the favorite by pedigree of the equipment. Questionable jockey.
8mil shares short on a stock that averages 9mil/day or on a low day (like yesterday) of 3mil makes for a tight squeeze to get out of. It’s not about the OS, it’s about the ability to cover on low relative trading volume. Right now they’re in trouble, if it keeps going higher their margin will get called.
Oh I’m sure ModeRNA is first with Fauci in the West Wing.
Yep, I moved all my shares to cash status by putting limit sell orders in for $100 tonight ... just to tighten the squeeze a little. I like to leave it in margin for awhile to give them confidence it’s there and then when the trap is set..... we squeeze hard.
That’s the pinks for ya. Upside down Longs frantic for an out.
Doesn’t help that most pinks are in fact scams so everyone is gun shy and highly skeptical already. Greg’s lack of follow through on his statements doesn’t help either...
Nasty position they are in... this should easily be at 30 cents PPs.
The twitter post says “moldings”
They should call the short investors, I doubt any longs would be interested. Oh wait, the shorts SHOULD HAVE profited from the supposed scam so why would they sue? Can’t sue for ignorance.
What a joke...
Covid! Meet the demand first! That should be the priority. They already posted pictures of the moldings... why not the completed units?
He did post a picture of the plastic moldings they received and he was ridiculed for it.
So... doubtful he’ll provide that info again.
The RX3000 we are making locally in Worcester MA at our facility. All of the parts are also acquired in the USA. The molding is done in Western MA with Company owned molds. Here is an image of some of last weeks production. pic.twitter.com/9BEj8xcnu3
— Vystar Corporation (@VystarCompany) March 30, 2020
Thought I read that the commercial business stays with VYST and the retail gets spinoff. Big Steve wants the 3000 unit revs for the holding company (VYST) as he needs revs for Vytex development.
Forget Greg BS. He’s the reason it’s at a penny. We’re taking big daddy Steve making corporate deals that generate revenue.
Maybe big daddy Steve choked him off on details lol.
If we can just get a little evidence from Greg it would be easy!!!